XOM vs. EDIT
XOM (Exxon Mobil Corporation) and EDIT (Editas Medicine, Inc.) are both stocks. XOM operates in Oil & Gas Integrated (Energy), while EDIT operates in Biotechnology (Healthcare). Over the past 10 years, XOM returned 9.64%/yr vs -22.22%/yr for EDIT. At a 0.11 correlation, their price movements are largely independent.
Performance
XOM vs. EDIT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XOM achieves a 23.81% return, which is significantly higher than EDIT's 21.95% return. Over the past 10 years, XOM has outperformed EDIT with an annualized return of 9.64%, while EDIT has yielded a comparatively lower -22.22% annualized return.
XOM
- 1D
- 0.28%
- 1M
- -6.91%
- YTD
- 23.81%
- 6M
- 25.40%
- 1Y
- 35.30%
- 3Y*
- 15.15%
- 5Y*
- 23.23%
- 10Y*
- 9.64%
EDIT
- 1D
- 2.46%
- 1M
- -4.58%
- YTD
- 21.95%
- 6M
- -1.19%
- 1Y
- 26.90%
- 3Y*
- -39.82%
- 5Y*
- -41.79%
- 10Y*
- -22.22%
XOM vs. EDIT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XOM Exxon Mobil Corporation | 23.81% | 15.98% | 11.26% | -6.26% | 87.41% | 57.58% | -36.21% | 7.23% | -15.09% | -3.81% |
EDIT Editas Medicine, Inc. | 21.95% | 61.42% | -87.46% | 14.21% | -66.59% | -62.13% | 136.78% | 30.15% | -25.97% | 89.34% |
Correlation
The correlation between XOM and EDIT is -0.17, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.01 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.06 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2016 | 0.11 |
The correlation between XOM and EDIT shifts across timeframes, from -0.17 (1 year) to 0.11 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
XOM:
$614.94B
EDIT:
$244.70M
XOM:
$5.93
EDIT:
-$1.21
XOM:
1.93
EDIT:
6.29
XOM:
2.42
EDIT:
55.51
XOM:
$326.01B
EDIT:
$35.86M
XOM:
$83.11B
EDIT:
$35.86M
XOM:
$60.44B
EDIT:
-$76.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XOM vs. EDIT — Risk / Return Rank
XOM
EDIT
XOM vs. EDIT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Exxon Mobil Corporation (XOM) and Editas Medicine, Inc. (EDIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XOM | EDIT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.41 | ||
| Sortino ratioReturn per unit of downside risk | +1.11 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.11 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 2.45 | 0.25 | +2.20 |
| Martin ratioReturn relative to average drawdown | 6.56 | 0.43 | +6.13 |
Loading charts...
Drawdowns
XOM vs. EDIT - Drawdown Comparison
The maximum XOM drawdown since its inception was -62.40%, smaller than the maximum EDIT drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for XOM and EDIT.
Loading charts...
Drawdown Indicators
| XOM | EDIT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.40% | -98.92% | +36.52% |
Max Drawdown (1Y)Largest decline over 1 year | -15.69% | -59.88% | +44.19% |
Max Drawdown (3Y)Largest decline over 3 years | -18.92% | -91.18% | +72.26% |
Max Drawdown (5Y)Largest decline over 5 years | -20.51% | -98.66% | +78.15% |
Max Drawdown (10Y)Largest decline over 10 years | -61.34% | -98.92% | +37.58% |
Current DrawdownCurrent decline from peak | -13.68% | -97.24% | +83.56% |
Average DrawdownAverage peak-to-trough decline | -10.20% | -62.63% | +52.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.84% | 34.03% | -28.19% |
Volatility
XOM vs. EDIT - Volatility Comparison
The current volatility for Exxon Mobil Corporation (XOM) is 9.08%, while Editas Medicine, Inc. (EDIT) has a volatility of 32.34%. This indicates that XOM experiences smaller price fluctuations and is considered to be less risky than EDIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XOM | EDIT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.08% | 32.34% | -23.26% |
Volatility (6M)Calculated over the trailing 6-month period | 20.51% | 61.63% | -41.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.51% | 94.75% | -70.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.77% | 94.12% | -67.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.20% | 83.80% | -55.60% |
Dividends
XOM vs. EDIT - Dividend Comparison
XOM's dividend yield for the trailing twelve months is around 2.78%, while EDIT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EDIT Editas Medicine, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XOM Exxon Mobil Corporation | 2.78% | 3.32% | 3.57% | 3.68% | 3.22% | 5.70% | 8.44% | 4.92% | 4.74% | 3.66% | 3.30% | 3.69% |
Financials
XOM vs. EDIT - Financials Comparison
This section allows you to compare key financial metrics between Exxon Mobil Corporation and Editas Medicine, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
XOM and EDIT have a correlation of -0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EDIT has higher volatility (32.34%) compared to XOM (9.08%). In terms of maximum drawdown, XOM dropped -62.40% vs EDIT's -98.92%.
XOM currently has the higher Sharpe Ratio (1.57 vs 0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XOM and EDIT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer